CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Biomarkers to predict the clinical outcome of hepatitis delta
DOI 10.1055/s-0034-1397213
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Wranke, BC Serrano, S Ernst, B Heidrich, J Kirschner, B Bremer, S Hardtke, M Cornberg, A Koch, MP Manns, CS Falk, H Wedemeyer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Hepatitis delta is the most severe form of viral hepatitis. Pegylated interferon alpha is effective in only 25 – 30% of patients and associated with frequent side effects. Thus, it is crucial to identify patients with benign courses of liver disease who may not require treatment. We recently introduced a baseline-event-anticipation (BEA)-Score for hepatitis delta considering thrombocytes, bilirubin, INR,…
Zitieren
Zitierempfehlung
A Wranke, BC Serrano, S Ernst, B Heidrich, J Kirschner, B Bremer, S Hardtke, M Cornberg, A Koch, MP Manns, CS Falk, H Wedemeyer (2015) Biomarkers to predict the clinical outcome of hepatitis delta. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0034-1397213
Mit CareLit weiterarbeiten